ADLM Middle East

  • Times
    ADLM Middle East 2024 information will be available later this year.

Opening and Welcome

Mark J. Golden, FASAE, CAE | CEO, AACC
Saeed Al Amoudi, MBBS, MD | CEO Al Borg Medical Laboratories

Plenary: Overcoming the Challenges of Emerging Infectious Diseases: Lessons Learned from the COVID-19 Experience

Christina Lockwood, PhD, DABCC, DABMGG

Session 1: Everyday Testing Challenges in Laboratory Medicine

  • Dealing with Everyday Testing Emergencies: Examples and Practical Solutions
    Patti Jones, PhD, DABCC, FADLM
  • Preanalytical Sample Transport/Storage
    Joe El-Khoury, PhD, DABCC, FADLM
  • Optimizing Design and Construction in Complex Laboratory Settings
    James Donnelly, PhD, DABCC, FADLM, FCACB

Industry Workshops, Exposition, and Lunchbreak

Session 2: Laboratory Management and Quality Assurance

  • Development, Implementation and Validation of Moving Averages in a Hospital-Based Laboratory
    Mark A. Cervinski, PhD, DABCC
  • Proficiency Testing and Quality Assessment
    Ola Elgaddar, MD, PhD, MBA
  • Variability In, Variability Out: Essentials of Quality Assurance in NGS
    Christina Lockwood, PhD, DABCC, DABMGG

Exposition continued and Break

Session 3: Advances and Biomarkers in Neurological Disease and Biomarkers

  • Biochemical Markers for the Diagnosis of Neuro-inflammatory Disorders
    Anu Jacob, MD, DM FRCP
  • Alzheimer's Disease
    Mari DeMarco, PhD, DABCC, FCACB
  • Using the APE2 Score to Triage Paraneoplastic Profiles
    Mark A. Cervinski, PhD, DABCC

Plenary: Providing Value Beyond Values: The Role of the Clinical Biochemist as a Consultant and a Coach

Mark A. Cervinski, PhD, DABCC
Laila Abdel Wareth, MBBCh, FCAP, FRCPC, EMHCA

Session 4: Big Data and Machine Learning in Clinical Laboratories

  • A Path to Sharing and Integrating Traceable, Clinical Laboratory Data
    Thomas Durant, MD
  • Digitalizing Medical Laboratories
    Zulfiqar Shaikh
  • The State of Interoperability and External Laboratory Results
    Thomas Durant, MD

Industry Workshops, Exposition, and Lunchbreak

Session 5: Emerging Biomarkers and Technologies: The Future of Lab Medicine

  • Biomarkers of Acute Kidney Injury: Highlights from the AACC Academy Guidance Document
    Joe El-Khoury, PhD, DABCC, FADLM
  • The Promise and Pitfalls of Cell-Free DNA for Personalized Medicine
    Christina Lockwood, PhD, DABCC, DABMGG
  • Proteoforms and Their Expanding Role in Laboratory Medicine
    Mari DeMarco, PhD, DABCC, FCACB

Exposition continued and Break

Session 6: Advances and Biomarkers in Neurological Disease and Biomarkers

  • Biomarkers of Preeclampsia
    Manal Mohamed Kamal
  • Newborn Screening
    Mohamed Elsammak, MD, MSc, PhD, FRCPath, CCT
  • Pediatric Reference Intervals: CALIPER and Beyond
    Patti Jones, PhD, DABCC, FADLM